EUVIMEDEUVIMED entdecken
Crossref

Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy

Hao Guo, Zhong Shao, Gang Wang iD, Yangyang Cheng iD, Shiyong Zhang iD

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c04383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Hao Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Thioctic Acid, Nanoparticles, Sulfides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the pleiotropic anticancer potential of the endogenous gasotransmitter hydrogen sulfide (H2S), achieving sustained and adequate intratumoral H2S supply remains a persistent challenge, hindering its advancement as a stand-alone therapeutic modality. Herein, we introduce cross-linked lipoic acid trisulfide nanoparticles (cLATN) that integrate both the H2S donor and transporter within a single precursor, wherein each unit theoretically yields one molecule of H2S, enabling stoichiometric H2S loading. cLATN effectively enter tumor cells via thiol-mediated uptake and are depolymerized by glutathione to trigger sufficient H2S release in tumor tissues for more than 48 h, far surpassing current H2S-based anticancer agents, which generally persist for only a few hours. Therapeutically, cLATN achieve an impressive tumor inhibition rate of 83% with favorable biocompatibility, far exceeding the clinical agent doxorubicin in both efficacy and safety. This work affirms its potential for cancer treatment, renewing interest in positioning H2S intervention as a stand-alone modality toward broader clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen SulfideThioctic AcidNanoparticlesSulfidesNeoplasmsAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorDoxorubicin

Stichwörter der Autor:innen

cancer therapycross-linked nanoparticlesdrug deliveryhydrogen sulfidetrisulfide

Substanzen

Hydrogen SulfideThioctic AcidSulfidesAntineoplastic AgentsDoxorubicin

Autor:innen und Institutionen

  • College of Biomedical Engineering and National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.

ORCID-Profile: Gang Wang, Yangyang Cheng, Shiyong Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Guo, H., Shao, Z., Wang, G., Cheng, Y., & Zhang, S. (2025). Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c04383

Vancouver

Guo H, Shao Z, Wang G, Cheng Y, Zhang S. Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c04383

BibTeX
@article{Guo2025,
  author = {Guo, Hao and Shao, Zhong and Wang, Gang and Cheng, Yangyang and Zhang, Shiyong},
  title = {Cross-Linked Lipoic Acid Trisulfide Nanoparticles: Revisiting H 2 S Intervention as a Stand-alone Modality for Cancer Therapy},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c04383}
}
Kostenlos starten →